BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1583354)

  • 1. Overexpression of c-Ki-ras and c-fos in human pancreatic carcinomas.
    Wakita K; Ohyanagi H; Yamamoto K; Tokuhisa T; Saitoh Y
    Int J Pancreatol; 1992 Feb; 11(1):43-7. PubMed ID: 1583354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene expression in endocrine pancreatic tumors.
    Höfler H; Ruhri C; Pütz B; Wirnsberger G; Hauser H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(6):355-61. PubMed ID: 2904191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of c-myc and c-ki-ras oncogene in human pancreatic carcinoma].
    Li DC
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):30-2. PubMed ID: 1396043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Overexpression of c-myc, c-fos and Harvey ras oncogenes in renal cancers--analysis at the messenger RNA levels].
    Kunimi K; Uchibayashi T; Hisazumi H
    Nihon Hinyokika Gakkai Zasshi; 1991 Dec; 82(12):1924-9. PubMed ID: 1779495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation.
    Ahmed MM; Sheldon D; Fruitwala MA; Venkatasubbarao K; Lee EY; Gupta S; Wood C; Mohiuddin M; Strodel WE
    Int J Cancer; 2008 Jan; 122(1):63-70. PubMed ID: 17893871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oncogene expression and point mutation in human pancreatic adenocarcinomas].
    Li DC; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):152-5. PubMed ID: 1477938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance.
    Nagai MA; Habr-Gama A; Oshima CT; Brentani MM
    Dis Colon Rectum; 1992 May; 35(5):444-51. PubMed ID: 1373678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
    Cui Q; Wang Z; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-myc, c-raf-1, and c-Ki-ras in azaserine-induced pancreatic carcinomas and growing pancreas in rats.
    Silverman JA; Kuhlmann ET; Zurlo J; Yager JD; Longnecker DS
    Mol Carcinog; 1990; 3(6):379-86. PubMed ID: 2278633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma.
    Egawa S; Kadmon D; Miller GJ; Scardino PT; Thompson TC
    Mol Carcinog; 1992; 5(1):52-61. PubMed ID: 1543541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of c-myc and c-fos mRNA in colorectal carcinoma in man.
    Klimpfinger M; Zisser G; Ruhri C; Pütz B; Steindorfer P; Höfler H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(3):165-71. PubMed ID: 1980763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of multiple oncogenes in human esophageal carcinomas.
    Wong FH; Hu CP; Chiu JH; Huang BS; Chang JP; Lin PJ; Chien KY; Chang C
    Cancer Invest; 1994; 12(2):121-31. PubMed ID: 8131089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversal of malignant cell phenotype of human pancreatic adenocarcinoma cell line by recombinant retroviral vector expressing antisense Ki-ras].
    Li H; Wang Z; Liu T
    Zhonghua Bing Li Xue Za Zhi; 1995 Oct; 24(5):288-91. PubMed ID: 8745475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-ras activation and expression in transformed mouse lung cell lines.
    Pan YH; Nuzum EO; Hanson LA; Beer DG
    Mol Carcinog; 1990; 3(5):279-86. PubMed ID: 2244960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.
    Rall CJ; Yan YX; Graeme-Cook F; Beauchamp R; Yandell DW; Povoski SP; Rustgi AK
    Pancreas; 1996 Jan; 12(1):10-7. PubMed ID: 8927612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis, and pancreatic adenocarcinoma.
    Burmer GC; Rabinovitch PS; Loeb LA
    Environ Health Perspect; 1991 Jun; 93():27-31. PubMed ID: 1773797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas.
    Grünewald K; Lyons J; Fröhlich A; Feichtinger H; Weger RA; Schwab G; Janssen JW; Bartram CR
    Int J Cancer; 1989 Jun; 43(6):1037-41. PubMed ID: 2659539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenes in cancer of the pancreas.
    Sakorafas GH; Lazaris A; Tsiotou AG; Koullias G; Glinatsis MT; Golematis BC
    Eur J Surg Oncol; 1995 Jun; 21(3):251-3. PubMed ID: 7781791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.